This morning Medtronic and UnitedHealthCare announced first year results from their value-based relationship. Per a joint press release;
“Results from an analysis of over 6,000 members with diabetes on Medtronic MiniMed(TM) 630G and previous generation insulin pumps demonstrated 27 percent fewer preventable hospital admissions compared to plan participants who are on multiple daily injections of insulin (MDI). The analysis included a mix of members utilizing both standalone insulin pumps and pumps integrated with continuous glucose monitors (CGM).”
As the companies noted these results do not include any patients on the 670G but we suspect when this system . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.